Sodium Lactate Veterinary Grade API is the sodium salt of 2-hydroxypropanoic acid supplied as an active pharmaceutical ingredient for the manufacture of tablets, injectable solutions, hard capsules, powders, granules, premixes, and oral solutions. The anhydrous solid is identified by CAS 72-17-3 and the aqueous solution by CAS 867-56-1; the molecular formula is C₃H₅NaO₃ with a relative molecular mass of 112.06 g/mol. Representative model designations include SLC-VET-60, a sterile-filterable aqueous solution at 60.0–70.0% w/w sodium lactate; SLC-VET-P100, an anhydrous crystalline powder; SLC-VET-G50, a wet-granulated material on a silicon dioxide and microcrystalline cellulose carrier; and SLC-VET-PM50, a premix with 50.0% w/w sodium lactate on a hydrophobic flow aid. Assay, pH, water content, heavy metals, residual solvents, and microbiological tests are reported according to Ph. Eur. 2.2.20, Ph. Eur. 2.2.3, Ph. Eur. 2.2.32, Ph. Eur. 2.4.8, ICH Q3C, and USP Chapter 61/62. The product is not a finished veterinary medicinal product and is released only against a certificate of analysis and a batch-specific certificate of conformance.

The material is classified under veterinary active-substance GMP and is supplied according to EU GMP Part II or equivalent national veterinary GMP. The solid grade is milled and sieved using a pin mill equipped with a 0.5 mm screen; the solution grade is manufactured in a closed stainless steel 316L reactor with nitrogen overlay to prevent oxidative colour change. Batch records include raw-material identity by infrared spectroscopy (Ph. Eur. 2.2.24), chloride and sulfate by ion chromatography (Ph. Eur. 2.2.38), and residual lactic acid by high-performance liquid chromatography according to the monograph procedure. The enantiomeric excess for L-lactate is measured by chiral HPLC or polarimetry; SLC-VET-60 and SLC-VET-P100 are available with L-isomer content not less than 95.0%, while SLC-VET-PM50 may be racemic unless specified otherwise.

What Distinguishes the Veterinary Grade API from Technical-Grade or Feed-Grade Sodium Lactate?

Veterinary-grade material is differentiated from technical-grade and feed-grade sodium lactate by the simultaneous control of bacterial endotoxins, heavy metals, residual solvents, methanolic impurities, and subvisible particulate matter. Injectable-grade SLC-VET-60 is tested according to Ph. Eur. 2.6.14 and USP Chapter 85 for bacterial endotoxins; typical release limits for the aqueous solution are not more than 0.1 EU/mL, while solid SLC-VET-P100 intended for parenteral use is controlled to not more than 0.25 EU/mg. Technical-grade sodium lactate may not carry a bacterial endotoxin specification and may contain iron above 10 mg/kg, chloride above 500 mg/kg, and residual ethanol or methanol above ICH Q3C option 1 limits. Feed-grade material is typically acceptable for oral premix but lacks the identity, purity, and microbiological controls required by Ph. Eur. 2.6.12 and USP Chapter 61. The veterinary grade also controls the ratio of L-lactate to total lactate; enantiopure L-sodium lactate is specified where species-specific metabolic studies demonstrate faster clearance than racemic DL-lactate, although published data for this specific configuration in reptiles and neonatal foals is limited.

Injectable-grade sodium lactate is generally incorporated into lactated electrolyte solutions rather than administered as a neat solution. The finished formulation commonly contains 3.1 g/L sodium lactate anhydrous equivalent, corresponding to 28 mmol/L lactate, alongside sodium chloride, potassium chloride, and calcium chloride. Manufacturing requires water for injection, 316L stainless steel hold vessels, and hydrophobic vent filters with 0.2 µm polyvinylidene fluoride membranes. The pH of the bulk solution is adjusted to 6.0–7.3 with lactic acid or sodium hydroxide, and osmolality is matched to the target species range for lactated electrolyte products. Terminal sterilization is typically performed at 121 °C for 15 min or at 115 °C for 30 min; the thermal cycle is sufficient to achieve an F₀ of not less than 8 min for parenteral solutions. Under these conditions, sodium lactate remains chemically stable, but the solution must be cooled rapidly to below 40 °C to minimize lactide formation and pH drift. In-process monitoring by Ph. Eur. 2.2.3 and Ph. Eur. 2.2.38 is used to reject any lot with a pH shift greater than 0.3 pH units or osmolality outside the registered specification. Compatibility with type II soda-lime-silica glass and titanium-coated rubber stoppers is confirmed by extraction studies according to Ph. Eur. 3.2.1. Filling lines use ceramic rotary piston pumps; peristaltic silicone tubing is avoided because sodium lactate solutions can extract plasticizer. The bioburden of the bulk solution before terminal sterilization is maintained below 10 CFU/100 mL by Ph. Eur. 2.6.12. For large-volume parenterals, subvisible particulate matter is controlled by Ph. Eur. 2.9.19 and USP Chapter 788 to not more than 25 particles ≥10 µm per mL and not more than 3 particles ≥25 µm per mL.

Solid-Dose Processing Requires Moisture Control Below 0.8% and Defined Particle Size

Tablet and capsule manufacture using SLC-VET-P100 requires pre-drying to water content not more than 0.8% when the material has been stored at relative humidity above 60%, because sodium lactate absorbs surface moisture rapidly and can form agglomerates in low-shear tumble blenders. Direct-compression blends prepared with microcrystalline cellulose, sodium starch glycolate, and magnesium stearate show acceptable flow when the Carr index is maintained at 25–35 and the Hausner ratio is below 1.35. On a rotary tablet press operating at 40–80 rpm turret speed and precompression force 5–10 kN, capping and picking occur if residual moisture exceeds 1.2% or if the blend is compressed above 300 MPa ejection stress. Dry granulation by roller compaction at roll pressure 30–50 kN is used for SLC-VET-P100 because it avoids exposing the hygroscopic API to aqueous granulation fluid. When wet granulation is required for effervescent or rapid-dissolving veterinary tablets, purified water is used as binder at 2–3% weight gain and the granulate is dried in a fluid-bed dryer with inlet air temperature not exceeding 60 °C and outlet air dew point below 10 °C. Particle size distribution is controlled by Ph. Eur. 2.9.31 or USP Chapter 429; the target for direct compression is 90% of particles through 250 µm and not more than 30% below 75 µm.

Sodium lactate is incompatible in solid formulations with strong acids, certain aldehyde-based film coatings, and high concentrations of calcium salts because free lactic acid can esterify or form insoluble calcium lactate. In tablet cores containing citric acid, the local pH in the wetted mass can fall below 2.0, converting sodium lactate to lactic acid and increasing cohesive force. Granulation solvent pH is therefore adjusted to 5.5–6.5, and acid is added only after the granulate is dried to water content below 1.0%.

Table 1 summarizes representative release data for the four model designations; lot-specific limits may be tightened according to the target species and route of administration.

Granular and premix products are blended into oral rehydration powders for calves, piglets, and poultry at inclusion rates that require segregation control in ribbon blenders with a fill volume of 60–70% and agitator speed 20–40 rpm. SLC-VET-G50 is wet-granulated using purified water as binder on a microcrystalline cellulose and silicon dioxide carrier; the final granule is sieved to 180–850 µm, with fines below 15% through a 106 µm sieve. SLC-VET-PM50 is dry-extended with hydrophobic fumed silica at 0.5–1.0% to reduce caking during storage at 25 °C and 60% RH. In feed-premix operations, the API is added before vitamin and trace mineral premixes to avoid localized moisture uptake from choline chloride and ferrous sulfate, which can cause the granules to soften and stick to the blender walls. Batch-to-batch variance in flow is monitored using Ph. Eur. 2.9.36 powder flow tests; a typical SLC-VET-G50 batch exhibits compressibility index below 20 and flow rate through a 15 mm orifice above 10 g/s, while SLC-VET-PM50 may show higher inter-batch variation when stored above 70% RH. Feed premix homogeneity is evaluated by sampling 10 locations in a ribbon blender and assaying sodium by Ph. Eur. 2.2.22 atomic emission spectrometry; the relative standard deviation after 10 min blending should be below 5%.

When Sodium Lactate Is Compounded in Oral Rehydration Premixes Above 120 mmol/kg

At sodium lactate additions corresponding to more than 120 mmol/kg in a dry oral rehydration formulation, the finished premix becomes noticeably hygroscopic and the sodium concentration can exceed the manageable oral sodium load for neonatal calves if osmolarity is not adjusted with non-ionic energy sources. In this concentration range, the premix should be packed in aluminum-foil-lined bags with a moisture vapor transmission rate below 0.5 g/m²/day at 37.8 °C and 90% RH, because water uptake changes the granular integrity and can initiate Maillard reactions when reducing sugars are present. Palatability in swine and poultry formulations is maintained when sodium lactate contributes not more than 60–80% of total sodium, with the remainder supplied as sodium chloride; above this range, bitter-lactate off-notes reduce voluntary intake in some production-scale farm studies, though published data for this specific configuration in nursery pigs is limited. The metabolic conversion of lactate to bicarbonate is hepatic; in acidotic calves, blood bicarbonate rises over 30–60 min following intravenous treatment, whereas oral administration produces a slower response that depends on abomasal emptying and rumen closure.

Oral solution manufacture generally dissolves SLC-VET-P100 in purified water at 20–25 °C under low-shear agitation; complete dissolution is achieved within 15–30 min when the batch volume is below 500 L. The resulting solution is filtered through a 0.45 µm polyethersulfone membrane and filled into amber polyethylene terephthalate bottles if the formulation contains light-sensitive vitamins. Hard capsule manufacture with sodium lactate is limited to moisture-resistant capsule shells such as hydroxypropyl methylcellulose with a shell water content below 8%, because gelatin shells soften when the fill blend releases free moisture above 45% RH. Capsule fill blends are typically dry-granulated SLC-VET-P100 with pregelatinized starch, and the target fill weight is controlled to ±3% on an automatic capsule machine at 30,000–60,000 capsules/h. Published stability data for sodium lactate in capsule formulations under accelerated conditions is limited; therefore, real-time stability studies at 25 °C and 60% RH are required for each new formulation.

Comparative Alkalizing Equivalents and Compatibility Boundaries for Veterinary Formulations

Sodium lactate is selected over sodium bicarbonate when carbon dioxide release in the stomach may produce bloat or metabolic alkalosis. Sodium bicarbonate has a relative molecular mass of 84.01 g/mol and reacts directly with gastric acid, generating carbon dioxide; sodium acetate has a relative molecular mass of 82.03 g/mol and produces bicarbonate through aerobic metabolism but does not include the lactic acid buffering capacity. Calcium lactate is used when both calcium and lactate are required, but its solubility in water at 25 °C is approximately 5 g/100 mL for the pentahydrate, which limits use in high-volume injectable solutions. Sodium lactate is monovalent and does not form insoluble phosphate precipitates in total parenteral nutrition mixtures, whereas calcium lactate can precipitate with phosphate buffers at pH above 6.0. In oral feline and canine formulations, sodium lactate is preferred over sodium acetate when a more neutral taste and less salivary response are required, although published sensory data in companion animals is limited.